| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2012-09-11 17:32:20 UTC |
|---|
| Update Date | 2023-02-21 17:19:11 UTC |
|---|
| HMDB ID | HMDB0029738 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Indole-3-methyl acetate |
|---|
| Description | Indole-3-methyl acetate, also known as methyl indole-3-acetate (methyl-IAA), is a catabolite of tryptophan converted by the gut microbiota. After absorption through the intestinal epithelium, tryptophan catabolites enter the bloodstream and are later excreted in the urine (PMID: 30120222 ). Pediatric enthesitis-related arthritis (ERA) patients (i.e. spondyloarthropathy associated with inflammatory bowel disease) have intestinal inflammation and decreased gut microbial diversity. Such alterations in the gut microbiota resulted in the reduction of tryptophan metabolism and several tryptophan metabolites in pediatric ERA fecal samples, including indole-3-methyl acetate (PMID: 27786174 ). Indole-3-methyl acetate is found in apple, and has been isolated from immature seeds of beach pea (Lathyrus maritimus), Vicia amurensis, wild soybean (Glycine soja), lobiya (Vigna catiang var. sinensis) and hyacinth bean (Dolichos lablab). |
|---|
| Structure | COC(=O)CC1=CNC2=C1C=CC=C2 InChI=1S/C11H11NO2/c1-14-11(13)6-8-7-12-10-5-3-2-4-9(8)10/h2-5,7,12H,6H2,1H3 |
|---|
| Synonyms | | Value | Source |
|---|
| beta-Indolylacetic acid methyl ester | ChEBI | | Indole-3-acetic acid, methyl ester | ChEBI | | Methyl 3-indolylacetate | ChEBI | | Methyl beta-indoleacetate | ChEBI | | Methyl beta-indolylacetate | ChEBI | | Methyl indol-3-ylacetate | ChEBI | | b-Indolylacetate methyl ester | Generator | | b-Indolylacetic acid methyl ester | Generator | | beta-Indolylacetate methyl ester | Generator | | Β-indolylacetate methyl ester | Generator | | Β-indolylacetic acid methyl ester | Generator | | Indole-3-acetate, methyl ester | Generator | | Methyl 3-indolylacetic acid | Generator | | Methyl b-indoleacetate | Generator | | Methyl b-indoleacetic acid | Generator | | Methyl beta-indoleacetic acid | Generator | | Methyl β-indoleacetate | Generator | | Methyl β-indoleacetic acid | Generator | | Methyl b-indolylacetate | Generator | | Methyl b-indolylacetic acid | Generator | | Methyl beta-indolylacetic acid | Generator | | Methyl β-indolylacetate | Generator | | Methyl β-indolylacetic acid | Generator | | Methyl indol-3-ylacetic acid | Generator | | Indole-3-methyl acetic acid | Generator | | 1H-Indole-3-acetic acid, methyl ester | HMDB | | beta -Indolylacetic acid methyl ester | HMDB | | IAA methyl ester | HMDB | | Indole-3-acetic acid methyl ester | HMDB | | INDOLE-3-acetIC ACID methylester | HMDB | | Meiaa | HMDB | | Methyl 1H-indol-3-ylacetate | HMDB | | Methyl 2-(1H-indol-3-yl)acetate | HMDB | | Methyl beta -indoleacetate | HMDB | | Methyl beta -indolylacetate | HMDB | | Methyl iaa | HMDB | | Methyl indole-3-acetate | HMDB | | Methylester OF 3-indoleacetic acid | HMDB | | Methyl (indol-3-yl)acetic acid | Generator | | (1H-Indol-3-yl)acetic acid methyl ester | HMDB | | Indolyl-3-acetic acid methyl ester | HMDB | | Methyl 1H-indole-3-acetate | HMDB | | Methyl-IAA | HMDB |
|
|---|
| Chemical Formula | C11H11NO2 |
|---|
| Average Molecular Weight | 189.2105 |
|---|
| Monoisotopic Molecular Weight | 189.078978601 |
|---|
| IUPAC Name | methyl 2-(1H-indol-3-yl)acetate |
|---|
| Traditional Name | methyl 1H-indol-3-ylacetate |
|---|
| CAS Registry Number | 1912-33-0 |
|---|
| SMILES | COC(=O)CC1=CNC2=C1C=CC=C2 |
|---|
| InChI Identifier | InChI=1S/C11H11NO2/c1-14-11(13)6-8-7-12-10-5-3-2-4-9(8)10/h2-5,7,12H,6H2,1H3 |
|---|
| InChI Key | KTHADMDGDNYQRX-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as indole-3-acetic acid derivatives. Indole-3-acetic acid derivatives are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Indoles and derivatives |
|---|
| Sub Class | Indolyl carboxylic acids and derivatives |
|---|
| Direct Parent | Indole-3-acetic acid derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Indole-3-acetic acid derivative
- 3-alkylindole
- Indole
- Substituted pyrrole
- Benzenoid
- Heteroaromatic compound
- Methyl ester
- Pyrrole
- Carboxylic acid ester
- Azacycle
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Carbonyl group
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 125 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.69 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.8762 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.48 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2076.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 429.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 152.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 244.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 267.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 490.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 478.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 124.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1090.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 425.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1282.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 392.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 361.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 365.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 383.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 65.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized |
|---|
| General References | - Stoll ML, Kumar R, Lefkowitz EJ, Cron RQ, Morrow CD, Barnes S: Fecal metabolomics in pediatric spondyloarthritis implicate decreased metabolic diversity and altered tryptophan metabolism as pathogenic factors. Genes Immun. 2016 Dec;17(7):400-405. doi: 10.1038/gene.2016.38. Epub 2016 Oct 27. [PubMed:27786174 ]
- Roager HM, Licht TR: Microbial tryptophan catabolites in health and disease. Nat Commun. 2018 Aug 17;9(1):3294. doi: 10.1038/s41467-018-05470-4. [PubMed:30120222 ]
- (). Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC.. .
|
|---|